SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001144204-16-118008
Filing Date
2016-08-10
Accepted
2016-08-10 15:42:36
Documents
1
Period of Report
2016-06-30
Effectiveness Date
2016-08-10

Document Format Files

Seq Description Document Type Size
1 NT 10-Q v446589_nt10q.htm NT 10-Q 29980
  Complete submission text file 0001144204-16-118008.txt   31141
Mailing Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017
Business Address 5600 BLAZER PARKWAY SUITE 200 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-35076 | Film No.: 161821413
SIC: 2835 In Vitro & In Vivo Diagnostic Substances